Log in
Enquire now
‌

INNOVATE BIOPHARMACEUTICALS, INC.

Innovate Biopharmaceuticals was the name of a clinical stage biotechnology company focused on developing therapeutics for autoimmune and inflammatory diseases. In 2019 Innovate merged with RDD Pharma and renamed the company 9 Meters Biopharma.

OverviewStructured DataIssuesContributors

Contents

innovatebiopharma.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Autoimmune disease
Autoimmune disease
Location
Raleigh, North Carolina
Raleigh, North Carolina
B2X
B2B
B2B
0
Legal Name
INNOVATE BIOPHARMACEUTICALS, INC.
Legal classification
Corporation
Corporation
Number of Employees (Ranges)
1 – 100
Full Address
Raleigh, North Carolina 27615, US
CIK Number
1,551,986
Place of Incorporation
Delaware
Delaware
Total Funding Amount (USD)
33,425,693
Latest Funding Round Date
January 2020

Other attributes

Company Operating Status
Active
Public/Private
Public

Innovate Biopharmaceuticals was the name of a clinical stage biotechnology company focused on developing therapeutics for autoimmune and inflammatory diseases. In 2019 Innovate merged with RDD Pharma and renamed the company 9 Meters Biopharma. 9 Meters is focused on gastrointestinal diseases.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like INNOVATE BIOPHARMACEUTICALS, INC.

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.